BDBM50115175 (5-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetylamino}-[1,3,4]thiadiazol-2-ylsulfanyl)-acetic acid::CHEMBL441464
SMILES: Cc1ccccc1NC(=O)Nc1ccc(CC(=O)Nc2nnc(SCC(O)=O)s2)cc1
InChI Key: InChIKey=HMUZIJUQPIVOID-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fibronectin receptor beta/Integrin alpha-4 (Homo sapiens (Human)) | BDBM50115175 ((5-{2-[4-(3-o-Tolyl-ureido)-phenyl]-acetylamino}-[...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Biogen Inc. Curated by ChEMBL | Assay Description Inhibition of Very late antigen 4 (VLA-4) and VCAM-Ig fusion protein interaction | J Med Chem 45: 2988-93 (2002) BindingDB Entry DOI: 10.7270/Q24J0GDJ | |||||||||||
More data for this Ligand-Target Pair |